Table 1 Clinico-pathological characteristics of all patients, their tumours and the relationship of each variable with overall survival

From: The differential expression of omega-3 and omega-6 fatty acid metabolising enzymes in colorectal cancer and its prognostic significance

Characteristic

Number patients

Percentage

Relationship with survival

Sex

Male

340

52.3

χ2=0.027, P=0.870

Female

310

47.7

 

Age (years)

<70

305

46.9

χ2=29.213, P <0.001

70

345

53.1

 

Screen detected

Yes

52

8

χ2=16.381, P <0.001

No

598

92

 

Tumour site

Proximal colon

261

40.2

Proximal vs distal, χ2=8.418, P =0.004

Distal colon

245

37.7

Distal vs rectal, χ2=0.906, P=0.341

Rectum

144

22.2

Colon vs rectum, χ2=0.098, P=0.754

Tumour differentiation

Well/moderate

600

92.3

χ2=0.976, P=0.323

Poor

50

7.7

 

Extra-mural venous invasion

Present

140

21.5

χ2=100.946, P <0.001

Absent

510

78.5

 

Microsatellite instability status

Defective

96

15.2

χ2=2.848, P=0.091

Intact

536

84.8

 

pT stage

T1

30

4.6

T1 vs T2, χ2=0.382, P=0.536

T2

114

17.5

T2 vs T3, χ2=24.739, P <0.001

T3

411

63.2

T3 vs T4, χ2=30.159, P <0.001

T4

95

14.6

 

pN stage

N0

364

56

N0 vs N1, χ2=54.071, P <0.001

N1

177

27.2

N1 vs N2, χ2=17.636, P <0.001

N2

109

16.8

 

Dukes stage

A

120

18.5

A vs B, χ2=5.059, P =0.025

B

244

37.5

B vs C, χ2=65.510, P <0.001

C

286

44

 
  1. Significant values are highlighted in bold.